Manage stand orders
Select Option

SYnAbs S.A.

48 rue Auguste Piccard, 6041 Gosselies
Belgium
Telephone +32 71 374880
Fax +32 71 374880
isoardj@synabs.be

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

This company is co-exhibitor of
AWEX - Wallonia Export & Investment

Contact

Julien Isoard

Business Director

Phone
+32483743904

Email
isoardj@synabs.be

Visit us

Unsettled / NN

16.11.2020

Topic

all-day

Custom monoclonals generation against haptens and difficult antigens

  • Antigen design and production: carbohydrates, lipids, neoepitopes, transmembrane proteins, toxins, epigenetic modifications
  • Mouse, Rats & Guinea pigs immunization schedules (DNA immunization, footpad...)
  • Fusion with proprietary myeloma cell lines
  • Screening against target antigen and cloning
  • Antibodies animal-free manufacturing and purification
  • Serum-free adaptation,
  • Up-stream & Down-Stream Processing development, scale-up and manufacturing up to several grams,
  • Development of custom immunoassays
  • Antibody engineering (ScFv, bispecific,...) & Humanization for therapeutic purposes

More Less

17.11.2020

Topic

08:00

Off-the-shelf unique primary monoclonal antibodies against complex antigens

  • Anti-DHT
  • Anti-aflatoxin
  • Anti-KIAA1199
  • Anti-SERPin

More Less

18.11.2020

Topic

all-day

Off-the-shelf unique secondary monoclonal antibodies

  • Anti-human (anti IgG4, anti-IgG, anti-IgM, anti-IgA, anti-IgE...)
  • Anti-camel (anti-VHH)
  • Anti-rat 
  • Anti-mouse
  • Anti-horse
  • Anti-chicken

More Less

Our range of products

Product categories

  • 03  Diagnostic tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.02  Diagnostic rapid tests
  • 03  Diagnostic tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.03  Diagnostic tests for cancer

Diagnostic tests for cancer

  • 03  Diagnostic tests
  • 03.04  Microbiology testing
  • 03.04.03  Rapid tests in microbiology

Rapid tests in microbiology

Our products

Product category: Immuno assay testing

Rat monoclonal antibodies against human repertoire

  • LO-hK-3 Rat anti-Human kappa light chain
  • LO-hL-2 Rat anti-Human lambda light chain
  • LO-hM-7 Rat anti-Human IgM heavy chain
  • LO-hD-11 Rat anti-Human IgD heavy chain
  • LO-hE-10 Rat anti-Human IgE heavy chain
  • LO-hA-8 Rat anti-Human IgA1 heavy chain
  • LO-hG-20 Rat anti-Human IgG heavy chain
  • LO-hIL2-1 Rat anti-Human IL2
  • LO-hIL2-2 Rat anti-Recombinant Human IL2
  • LO-hIL6-1 Rat anti-Human IL6
  • LO-CD1-a Rat Human Human CD1
  • LO-CD5-a Rat Human Human CD5
  • LO-CD6-a Rat Human Human CD6
  • LO-CD9 Rat Human Human CD9
  • LO-CDw41 Rat anti-Human Platelets glycoprotein complex IIb-IIIa
  • LO-MO1 Rat anti-Human CD14
  • LO-PanB-a Rat anti- Human CDW78
  • LO-Tact-1 Rat anti-Human IL2 receptor
  • LO-HIV1-1 Rat anti-Human p24 HIV-1
  • LO-hG4-1 Rat Human Human IgG4 

More Less

Product category: Immuno assay testing

Mouse monoclonal antibodies against rat isotypes

  • MARK-1 Mouse anti-Rat Kappa light chain
  • MARK-3 Mouse anti-Rat Kappa light chain
  • MARL-15 Mouse anti-Rat Rat Lambda light chain
  • MAR(K+L) Mouse anti-Rat kappa + lambda light chain
  • MARM-4 Mouse anti-Rat IgM heavy chain
  • MARM-7 Mouse anti-Rat IgM heavy chain
  • MARD-3 Mouse anti-Rat IgD heavy chain
  • MARA-1 Mouse anti-Rat IgA heavy chain
  • MARE-1 Mouse anti-Rat IgE heavy chain
  • MARG1-1 Mouse anti-Rat IgG1 heavy chain
  • MARG2a-1 Mouse anti-Rat IgG2a heavy chain
  • MARG2b-8 Mouse anti-Rat IgG2b heavy chain
  • MARG2c-3 Mouse anti-Rat IgG2c heavy chain
  • MARG-COC-1 Mouse anti-Rat IgG1,IgG2a,IgG2b, IgG2c heavy chain 

More Less

Product category: Immuno assay testing

Irrelevant and isotype control antibodies

  • LO-DNP: rat anti-DiNitroPhenol
  • MA-DNP: mouse anti-DiNitroPhenol
  • IR202 : Rat IgM kappa
  • IR22: Rat IgA kappa
  • IR2: Rat IgE kappa
  • IR595: Rat IgG1 kappa
  • IR31: Rat IgG1 lambda
  • IR418: Rat IgG2a kappa
  • IR863 Rat / IgG2b kappa
  • IR304 Rat / IgG2c kappa

More Less

Product category: Immuno assay testing

Guinea pig monoclonal antibodies against hormone steroid

GP-DHT-1: Cobaye anti-Human Dihydrotestosterone

More Less

Product category: Immuno assay testing

Monoclonal antibodies against mycotoxins

MA-AFLA: Mouse antibody against aflatoxine

More Less

Product category: Immuno assay testing

Rat monoclonal antibodies against camel repertoire

LO-VHH: rat anti-llama VHH

More Less

Product category: Immuno assay testing

Custom mAb generation against difficult antigen and haptens

  • Antigen design and production: carbohydrates, lipids, neoepitopes, transmembrane proteins, toxins, epigenetic modifications
  • Mouse, Rats & Guinea pigs immunization schedules (DNA immunization, footpad...)
  • Fusion with proprietary myeloma cell lines
  • Screening against target antigen and cloning
  • Antibodies animal-free manufacturing and purification
  • Serum-free adaptation,
  • Up-stream & Down-Stream Processing development, scale-up and manufacturing up to several grams,
  • Development of custom immunoassays
  • Antibody engineering (ScFv, bispecific,...) & Humanization for therapeutic purposes

More Less

Product category: Diagnostic rapid tests

Rat monoclonal antibodies against human repertoire

Anti-IgG, anti-IgM, and anti-IgA for the monitoring of immune response.
Already included in COVID-19 test rapid diagnostic tests!

Unlike the products marketed to date, the test developed by SYnabs, Coris BioConcept, Unisensor, and Bio- X Diagnostics, is the only rapid solution (developed in different formats) that can detect an immune response against two specific Coronavirus / Covid-19 "markers". This 100% Walloon innovation makes it possible to detect not only a greater number of people who have been contaminated but also to identify those who have developed a neutralizing, potentially protective immune response.

More Less

Product category: Rapid tests in microbiology

Antibiotic resistance identification

The objective of the RADAR project is to develop new tests for the identification of antibiotic resistance.

This project, carried out in partnership by the companies Coris BioConcept and Synabs, involves the creation of reagents necessary for the development of new tests as well as the improvement of existing tests in order to extend their field of use and enable Coris BioConcept to extend the R.E.S.I.S.T. range dedicated to these identifications.

More Less

Product category: Diagnostic tests for cancer

Epigenetic modifications identification

The MENAC project aims to develop new tests for the identification of epigenetic changes in histones such as acetylations, methylations, phosphorylation, and mutations.

This project, carried out in partnership by Volition and Synabs, involves the creation of monoclonal antibodies necessary for the development of new tests for the early diagnosis of cancer in humans and animals.

More Less

Company news

Date

Topic

Download

Oct 8, 2020

SYnabs, Unisensor, Coris BioConcept and Bio-X Diagnostics, have together developed a COVID individual rapid test that is a world premiere

Unlike the products marketed to date, the test developed by SYnabs, Coris BioConcept, Unisensor, and Bio- X Diagnostics, is the only rapid solution (developed in different formats) that can detect an immune response against two specific Coronavirus / Covid-19 "markers". This 100% Walloon innovation makes it possible to detect not only a greater number of people who have been contaminated but also to identify those who have developed a neutralizing, potentially protective immune response.

More Less

Oct 8, 2020

SYnabs & Biokit announce strategic collaboration on valproic acid antigen

SYnAbs & Biokit, A Werfen Company are proud to announce their success in the development of the best anti-valproic acid monoclonal antibody of the market! This case study is a new proof of the high efficiency of SYnAbs technologies for the generation of antibodies against haptens.

More Less

Sep 24, 2020

SYnAbs and Volition ink strategic deal on epigenetic modifications targeting

SYnabs will develop monoclonal antibodies of mice, rats, and guinea pigs against 16 different post-translational modifications on histones including methylation, acetylation, phosphorylation, and mutations.

More Less

About us

Company details

SYnAbs' mission is to generate innovative antibodies against poor immunogenic compounds and complex antigens. Either as a custom service, or as a catalog product, you can benefit from SYnAbs technologies to get access to singular monoclonal antibodies.

The benefits of SYnAbs unique technologies?
  • Extreme specificity monoclonal antibodies
  • Higher affinity binder monoclonal antibodies
  • >90% success rate for small, difficult and poor immunogenic antigens
  • Additional epitope recognition
  • High and stable producer clones
  • Access to multiple immune repertoires
  • Raising antibodies against difficult to express antigens
  • Generating antibodies against conformation sensitive targets thanks to DNA immunization

More Less

Company data

Sales volume

< 1 Mio US $

Export content

max. 75%

Number of employees

1-19

Foundation

2015

Area of business

Diagnostics